about
Novel human genetic variants associated with extrapulmonary tuberculosis: a pilot genome wide association studyEffect of CYP2B6, ABCB1, and CYP3A5 polymorphisms on efavirenz pharmacokinetics and treatment response: an AIDS Clinical Trials Group studyCharacterization of conserved and nonconserved imprinted genes in swineEmbracing Integrative Multiomics ApproachesDifferences in X-chromosome transcriptional activity and cholesterol metabolism between placentae from swine breeds from Asian and Western originsShift work in nurses: contribution of phenotypes and genotypes to adaptationIdentification and replication of loci involved in camptothecin-induced cytotoxicity using CEPH pedigreesGenome-Wide Association Study in Immunocompetent Patients with Delayed Hypersensitivity to Sulfonamide AntimicrobialsGenetic Predictors of Cardiovascular Mortality During Intensive Glycemic Control in Type 2 Diabetes: Findings From the ACCORD Clinical Trial.Initial evaluation of nighttime restlessness in a naturally occurring canine model of osteoarthritis pain.Single-nucleotide polymorphism data support the general unrelatedness of the males in the agricultural health study.Association of dilated cardiomyopathy with the striatin mutation genotype in boxer dogs.Human natural killer T cells are heterogeneous in their capacity to reprogram their effector functionsPower of grammatical evolution neural networks to detect gene-gene interactions in the presence of error.The effect of alternative permutation testing strategies on the performance of multifactor dimensionality reduction.Evaluation of thromboelastography for prediction of clinical bleeding in thrombocytopenic dogs after total body irradiation and hematopoietic cell transplantation.A novel canine model of immune thrombocytopenia: has immune thrombocytopenia (ITP) gone to the dogs?Polymorphisms in IL-1beta, vitamin D receptor Fok1, and Toll-like receptor 2 are associated with extrapulmonary tuberculosis.An Introduction to Terminology and Methodology of Chemical Synergy-Perspectives from Across Disciplines.A comparison of internal validation techniques for multifactor dimensionality reduction.Auriculotherapy for pain management: a systematic review and meta-analysis of randomized controlled trials.A new explained-variance based genetic risk score for predictive modeling of disease riskGenome-wide association and pharmacological profiling of 29 anticancer agents using lymphoblastoid cell linesApplication of next generation sequencing to CEPH cell lines to discover variants associated with FDA approved chemotherapeutics.Use of RNA-seq to identify cardiac genes and gene pathways differentially expressed between dogs with and without dilated cardiomyopathy.Genomic profiling reveals extensive heterogeneity in somatic DNA copy number aberrations of canine hemangiosarcomaBeyond IC50s: Towards Robust Statistical Methods for in vitro Association Studies.The effect of retrospective sampling on estimates of prediction error for multifactor dimensionality reduction.An R package implementation of multifactor dimensionality reduction.Global tests of P-values for multifactor dimensionality reduction models in selection of optimal number of target genes.A comparison of internal model validation methods for multifactor dimensionality reduction in the case of genetic heterogeneity.Risk score modeling of multiple gene to gene interactions using aggregated-multifactor dimensionality reduction.Operative factors associated with short-term outcome in horses with large colon volvulus: 47 cases from 2006 to 2013.Genome-wide association studies in pharmacogenomics: successes and lessons.Population-based in vitro hazard and concentration-response assessment of chemicals: the 1000 genomes high-throughput screening study.Twice-daily application of HIV microbicides alter the vaginal microbiota.Genetic heterogeneity beyond CYP2C8*3 does not explain differential sensitivity to paclitaxel-induced neuropathy.Lymphoblastoid cell lines models of drug response: successes and lessons from this pharmacogenomic model.An investigation of gene-gene interactions in dose-response studies with Bayesian nonparametrics.Identification and simian immunodeficiency virus infection of CD1d-restricted macaque natural killer T cells.
P50
Q24618920-435B614A-CDB0-48EC-A74B-6903CEA03090Q24633579-E1630E40-6056-41F7-ACAC-3419CC0D42A5Q24647126-52BB9D45-8B88-4B07-88BE-B0F62039AB2DQ28078357-6DC6922B-24AC-4839-B1F8-C780DA8AABBBQ28284961-FF84F313-0B57-47D6-81B5-88B4FBE46132Q28387916-4C19D81F-8814-4816-A528-BEAE4E2863E7Q28478055-2737DD07-2E59-4D91-8405-D4CFD5E12FCEQ28550088-368626E9-6C6C-46DD-A6BB-8501FD2578F4Q30276113-63E0C267-1D94-4033-8ACB-C5485CC0473EQ30417960-9C338817-A3F8-4829-8AE9-C983655E3655Q30837766-F921471E-1DCC-499F-B629-59C21CE4D1B8Q33163271-52549703-4A4C-4365-9554-D035DFF1F0BFQ33267309-5E3BD777-F2EB-4B96-BDA8-ED3BAE290189Q33360980-936BE2FB-EB60-49C6-927D-F3D1FDBFA622Q33396570-B1188F0E-94F1-4652-AD55-BEBE091E99BDQ33414829-2264D976-CE4C-46FB-BF7C-077298AFA9F6Q33416544-60F1028F-E5D0-4478-986F-B641134A6F0EQ33536160-A8EEBF3D-7E40-4B00-A3D6-3C6078A15177Q33580906-1CDE1DDD-C1B2-4449-894B-250753118BBEQ33637901-241745BF-7AFF-4F95-B837-984D164009C5Q33721219-1E3DCE02-F247-4422-B350-C84EC3394CCFQ33734310-0A7D7D03-5882-4EBF-ADE7-D896CAABC75CQ33746404-48258C41-81F6-43BA-85F1-6BF6AEB241E9Q33799826-96CCAA3C-9F6B-4021-8A22-8A2534D80FF1Q33906767-D1D4DE62-3180-4363-8F05-1C34EA5653C6Q33919862-174F0555-49C7-42E2-9813-823101061B43Q34015085-467D6C84-3FD4-4F75-9540-319F0CFCD36FQ34203716-CB3C0048-F076-444E-91A3-7F278918EF09Q34208434-75A234D1-DD77-4329-A4AB-4C99EBFE1861Q34276551-1C3DA377-A145-4425-8E04-0036642AEC2AQ34309985-B02721D5-CC09-4F5D-A9F7-92F0F9696AE3Q34321157-B37E0FF4-DE54-4F20-B386-267D73BD6E8AQ34345564-B52C3875-E813-4115-987E-7CF069B63A07Q34415006-3336D1E0-8654-43E0-BB10-58B29B170A3DQ34459766-C04F4F49-1C2B-43FA-BF92-5236096A7492Q34515293-2A0A0B13-6683-40D8-9C67-FF001D1FB9F9Q34633385-4EA39C8A-95E0-4080-AFC0-46E575055DC3Q35068272-76A3246C-850C-4129-BECF-6576B66B949EQ35090595-ADB35A3E-F061-4A16-A93C-60A0252ACD58Q35104944-953703D0-B8F8-4372-B29E-B61721D405D7
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Alison Motsinger-Reif
@ast
Alison Motsinger-Reif
@en
Alison Motsinger-Reif
@es
Alison Motsinger-Reif
@nl
Alison Motsinger-Reif
@sl
type
label
Alison Motsinger-Reif
@ast
Alison Motsinger-Reif
@en
Alison Motsinger-Reif
@es
Alison Motsinger-Reif
@nl
Alison Motsinger-Reif
@sl
altLabel
Alison A Motsinger-Reif
@en
Alison A. Motsinger-Reif
@en
Alison Motsinger
@en
prefLabel
Alison Motsinger-Reif
@ast
Alison Motsinger-Reif
@en
Alison Motsinger-Reif
@es
Alison Motsinger-Reif
@nl
Alison Motsinger-Reif
@sl
P1053
I-4167-2018
P106
P21
P2456
m/AlisonAMotsinger
P31
P3829
P496
0000-0003-1346-2493